eu gastroesophageal reflux disease drugs and devices market

EU Gastroesophageal Reflux Disease Drugs and Devices Market, Market Segmented by Drug Class (Antacids, H2 Receptor Blockers, Proton Pump Inhibitors, Pro-Kinetic Agents), by Devices (Digi trapper, Bravo System, Stretta, Linx Reflux Management System, Muse, and Other Devices) - Growth, Trends and Forecast, 2019-2028

  • Published Date: 2022-12-26
  • Report ID: 138294
  • Pages: 200
  • Format: prudent report format

Report Overview

The EU Gastroesophageal Reflux Disease Drugs and Devices market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 0.93% during the forecast period

Gastroesophageal reflux disease(GERD) is a condition in which reflux of gastric contents into the esophagus produces frequent or severe symptoms that negatively affect the individual's quality of life or result in damage to esophagus, pharynx, or the respiratory tract



Market Drivers

The chances of GERD among patients coming for diagnosis at least once per week is in the range of 8.825.9 % in Europe. Associations like European Medicines Agency (EMA), Federal Institute for Drugs and Medical Devices, German Society of Gastroenterology, Digestive and Metabolic Diseases, etc. are the key regulatory bodies that are spreading awareness about GERD and other acid-associated maladies. This level of awareness is promoting the growth of the said market in Europe


1. EU Gastroesophageal Reflux Disease Drugs and Devices Market Overview
A. Market Size
2. EU Gastroesophageal Reflux Disease Drugs and Devices Growth Drivers
A. Growing trend of self-medication
B. Increasing awareness about GERD
C. Increasing occurrence of GERD disorders
D. Change in lifestyle
3. EU Gastroesophageal Reflux Disease Drugs and Devices Market Segmentation
A. By Drug Class
I. Antacids
II. H2 Receptor Blockers
III. Proton Pump Inhibitors
IV. Pro-Kinetic Agents
B. By Devices
I. Digi trapper
II. Bravo System
III. Stretta
IV. Linx Reflux Management System
V. Muse
VI. Other Devices
4. EU Gastroesophageal Reflux Disease Drugs and Devices Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A Abbott Laboratories Company overview, Product & Services, Strategies & Financials
B Astra Zeneca Company overview, Product & Services, Strategies & Financials
C Ausch Health Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.